Torrent Pharmaceuticals
Torrent Pharmaceuticals
Shareholder Return: 3-year, Sales Growth: 3-year CAGR, Return On Equity: 3-year average
At a Glance
-
Shareholder Return312%
-
Sales Growth28%
-
Return on Equity44 %
Why Super 50
The company lost 70 percent of its business when the Soviet Union collapsed in 1991. But brothers Sudhir and Samir Mehta have rebuilt the company brick by brick. A good track record of securing approvals for new drugs in the US, and a couple of strategic acquisitions, have made Torrent one of the fastest growing drug makers in India.
